Biocompatible, Biodegradable EPL/PCL Nanoparticles with Effective Antibacterial Activity

Many experimental and clinical data have demonstrated that antibiotic-resistance pathogens, such as Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus), may play a vital role in priming chronic inflammation. There is thus a great need to develop novel antibacterial materials, and particularly those that are less likely to lead to bacterial resistance.

Now, in a paper appearing recently in Science Bulletin, a team of scientists at the National Center for Nanoscience and Technology, China, led by Guangjun Nie and Yuliang Zhao, has designed and synthesized biocompatible and biodegradable ε-poly-lysine (EPL)/poly (ε-caprolactone) (PCL) nanoparticles (NPs), which have effective antibacterial activity and no significant cytotoxicity to mammalian cells.

Most clinically used antibiotics do not physically damage the cell membranes/walls, but rather target the cell wall and penetrate into the cell, inhibiting protein synthesis and DNA replication. As a result, bacterial morphology is preserved. Bacteria are increasingly growing resistant to conventional antibiotics. Biocompatible and biodegradable ε-poly-L-lysine (EPL)/poly (e-caprolactone) (PCL) copolymer was designed and synthesized. The amphiphilic EPL-PCL copolymer could easily self-assembled into mono-dispersed nanoparticles (NPs), which showed a broad-spectrum antibacterial activity against E. coli, S. aureus and Bacillus subtilis (B. subtilis). The NPs have been found that they can disrupt bacterial walls/membranes and induce the increasing in reactive oxygen species and alkaline phosphatase levels. More importantly, the self-assembled NPs induced the changes in bacterial osmotic pressure, resulting in cell invagination to form holes and cause the leakage of cytoplasm.

Taken together, these results suggest that the EPL-PCL NPs can be further developed to be a promising antimicrobial agent to treat infectious diseases as surfactants and emulsifiers to enhance drug encapsulation efficiency and antimicrobial activity.


Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.